Non-Idiopathic Scoliosis Treated With Tranexamic Acid
Status:
Terminated
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
Investigation of tranexamic acid (TXA) for reducing perioperative blood loss and transfusion
requirement in pediatric patients with secondary scoliosis undergoing posterior spinal
fusion.